Date: 2012-04-17
Type of information: Fundraising
Company: Sensorion (France)
Investors: Innobio (France)
Amount: €0.75 million
Funding type:
Planned used: This financing will allow Sensorion to continue its development, strengthen its management, and prepare for upcoming fundraisers.
Others: The InnoBio fund has invested 750,000 euros in the company Sensorion. This emerging pharmaceutical company pioneering has implemented an integrated platform for identification and in vivo and in vitro testing of new active compounds for the treatment of diseases associated with the inner ear. The company has been founded in 2009. It is based on the work of Christian Chabbert (U583 INSERM) at the Institute for Neuroscience of Montpellier. Sensorion has also recruited a new president, Laurent Nguyen, and strengthened its governance with the arrival of Eric de la Fortelle who joined the board of Sensorion as a non Executive Director.
Therapeutic area: Otorhinolaryngology
